Current jobs related to Chief RNA Therapeutics Strategist - Queenstown - Agency For Science, Technology And Research


  • Queenstown, New Zealand Agency For Science, Technology And Research Full time

    Job Description:As a Chief Innovation Strategist at the Agency For Science, Technology And Research, you will play a crucial role in driving innovation and growth within our organization. The successful candidate will be responsible for leading the development, management, and tracking of innovation projects, as well as collaborating with cross-functional...


  • Queenstown, New Zealand Agency For Science, Technology And Research Full time

    The Agency for Science, Technology and Research is a leading institution in cancer epigenetic research, seeking an exceptional Bioinformatics Research Fellow to join its esteemed Laboratory of Cancer Epigenetic Regulation. This highly respected laboratory, led by GIS Chief Scientific Officer Patrick Tan, aims to uncover novel cancer biomarkers through deep...


  • Queenstown, New Zealand Agency For Science, Technology And Research Full time

    Job OverviewThe Laboratory of Cancer Epigenetic Regulation, led by GIS Chief Scientific Officer Patrick Tan, is seeking a highly motivated Bioinformatics Research Fellow to join a multi-institutional effort employing deep multi-omics phenotyping to uncover cancer biomarkers correlating with clinical outcomes. This role will involve developing and applying...

Chief RNA Therapeutics Strategist

1 week ago


Queenstown, New Zealand Agency For Science, Technology And Research Full time
Job Overview

The Agency For Science, Technology And Research seeks a highly skilled professional to lead the development and implementation of RNA therapeutics research and development strategies. As the Director / Deputy Director, R&D Strategy, you will work closely with the Chief Scientific Officer and Executive Director to drive the national-level program in RNA therapeutics.

This is an exciting opportunity for a visionary leader to shape the future of RNA therapeutics in Singapore and establish the country as a world-class hub for nucleic acid therapies.